Nutcracker Therapeutics, Inc. is a biotechnology CRDMO company that combines advanced engineering with high-precision biosynthesis to unlock the promise of RNA. The company’s mission is to drive forward the development of safe and effective RNA-based personalized therapeutics through its complete technology platform, which encompasses the design, delivery, and manufacturing of RNA molecules. Armed with this high-tech advantage, Nutcracker Therapeutics’ unique scalable RNA platform significantly reduces costs and cycle times, while keeping the highest quality.
Looking for a particular Nutcracker Therapeutics employee's phone or email?
Nutcracker Therapeutics Questions
The Nutcracker Therapeutics annual revenue was $1 million in 2026.
Samuel Deutsch is the Chief Scientific Officer of Nutcracker Therapeutics.
37 people are employed at Nutcracker Therapeutics.
Nutcracker Therapeutics is based in Emeryville, California.
The NAICS codes for Nutcracker Therapeutics are [54171, 54, 541714, 541, 5417].
The SIC codes for Nutcracker Therapeutics are [873, 87].
Top Nutcracker Therapeutics Employees
-
Samuel Deutsch
Chief Scientific Officer at Nutcracker Therapeutics
California, United States24 -
Ian Wiener
EVP and General Counsel at Nutcracker Therapeutics
Los Angeles, CA, US24 -
Ole-Audun Haabeth
Senior Director at Nutcracker Therapeutics
Stanford, CA, US1 -
John C
Director of Financial Planning and Analysis at Nutcracker Therapeutics
California, United States2 -
Adrienne Sallets
Associate Director at Nutcracker Therapeutics
California, United States1 -
Sangeeta Nath
Associate Director at Nutcracker Therapeutics
Berkeley, CA, US35 -
43
Related Companies
